Hangzhou Tigermed Consulting Co.Ltd.



Quote for Hangzhou Tigermed Consulting Co.Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
300347
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8300347 quote

Summary for Hangzhou Tigermed Consulting Co.Ltd.

Hangzhou Tigermed Consulting Co., Ltd. is principally engaged in the research and development of pharmaceuticals and health products, as well as the provision of pofessional clinical research services. The Company mainly offers phase one to phase four clinical testing technical services, including the design of clinical testing programs, the selection and choosing of researchers and research centers, the organization of researcher meetings and the composing of final reports; data management services, including clinical testing data input, data inspection and data quality control; statistic analysis; register declaration; medical materials translation; clinical testing on-site services, as well as phase one clinical analysis and testing services, among others.

Profile for Hangzhou Tigermed Consulting Co.Ltd.

Full Name:Hangzhou Tigermed Consulting Co.Ltd.
Full Name in Chinese:杭州泰格医药科技股份有限公司 Short Name in Chinese:泰格医药
Symbol/Stock Code:
300347
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Ye Xiaoping
Secretary of the Board:
Cao Xiaochun
Phone:
+86-571-28887227
Fax:
+86-571-88211196
Official Website:www.tigermed.net
E-mail:ir@tigermed.net
Address:17F, Baoyi Chuangyi Building,No. 3760, Nanhuan Road,Binjiang District,HANGZHOU ZHJ 310053
IPO Subscription Date:
2012-08-07
Listing Date:
2012-08-17
IPO Issued Capital:
13400000
IPO Price:
37.88
IPO fees:
26421000 CNY
Money Raised by IPO:
507592000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
481171000 CNY
Open(Listing day):
- CNY
Close(Listing day):
- CNY
Diluted P/E ratio after IPO:
44.0500
Turnover rate(listing day):
-%

Financials for Hangzhou Tigermed Consulting Co.Ltd.

UPDATE:2012-10-22 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
46.3794
47.7918
31.7093
7.801
Net Profit Growth(%)
41.44
50.71
306.47
-
Return On Equity(ROE)(%)
6.94
33.86
33.96
18.41
Debt ratio(%)
5.02
21.81
20.11
34.32
Net Operating Cash Flow/Net Profit(%)
46.00
80.96
83.84
281.35

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.8700
1.1900
0.8000
0.2300
Diluted Earnings Per Share
0.0000
1.1400
0.7600
0.2300
Net Asset Value Per Share (NAVPS)
12.5200
3.5300
2.3300
1.4100
Additional Paid-In Capital Per Share
9.2434
0.6457
0.6457
0.3200
Retained Earnings Per Share
2.1567
1.7197
0.6339
0.0791
Net Cash Flow From Operatings Activities Per Share
0.4000
0.9700
0.6600
0.7300
Net Cash Flow Per Share
8.8329
1.0819
0.6256
-0.4090

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
708.5433
186.7583
119.9112
67.3881
Total Liabilities(Million)
35.6211
40.7322
24.1227
23.1306
Current Liabilities(Million)
34.3913
38.1582
23.2477
23.1306
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
557.4004
85.7255
42.4503
17.4248
Accounts Receivables(Million)
80.8862
45.0787
23.8135
17.7761
Deposit Received(Million)
14.8497
31.1681
18.6945
20.6914
Other Receivables(Million)
2.0892
4.4603
2.6445
1.4257
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
668.698
141.1608
93.3701
42.3716
Debt ratio(%)
5.02
21.81
20.11
34.32
Equity Ratio(%)
94.3700
75.5800
77.8600
62.8700
Current Ratio
18.7618
3.7628
3.8678
1.6251
Quick Ratio
18.7547
3.7603
3.8660
-

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
132.1463
182.7265
112.8177
64.5346
Net Cash Flow From Operatings Activities(Million)
21.333
38.6916
26.5858
21.9483
Net Cash Flow From Operatings Activities Change(%)
-28.85
45.53
21.13
-
Net Cash Flow(Million)
471.6749
43.2753
25.0255
-12.2699
Cash From Selling Commodities/Prime Revenue(%)
71.13
94.55
91.84
102.77
Net Cash Flow/Net Profit(%)
1016.99
90.55
78.92
-157.29
Cash Flow From Investing Activities(Million)
-23.6911
4.6449
-20.7641
-34.1652
Cash Flow From Financing Activities(Million)
474.4319
-0.055
19.2904
-

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
185.7877
193.2638
122.8441
62.7929
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
5.068
5.2878
4.6672
2.9288
Administrative Costs(Million)
29.1913
26.3369
16.3241
11.8571
Financing Costs(Million)
-2.2267
-0.1169
0.0264
-0.0935
Above Three Costs Change(%)
40.51
49.91
43.05
-
Operating Profit(Million)
50.8046
55.063
34.526
8.2103
Income From Investment(Million)
-
0.8774
0.0337
0.9402
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
4.2617
1.8871
1.769
-0.0068
Total Profit(Million)
55.0663
56.9501
36.295
8.2035
Corporate Income Tax(Million)
8.6755
8.8517
4.0584
0.6005
Net Profit(Million)
46.3794
47.7918
31.7093
7.801
Gross Profit Ratio(%)
48.59
47.68
48.09
38.42
Operating Margin(%)
27.34
28.49
28.10
13.07
Return On Equity(ROE)(%)
6.94
33.86
33.96
18.41

Announcements for Hangzhou Tigermed Consulting Co.Ltd.

Date: 2012-08-16
Title: IPO SHARE LISTING
The Company's 13.4 million shares (code:300347) in its initial public offering will be listed on the Shenzhen Stock Exchange on 17 August 2012.
Date: 2012-08-06
Title: IPO-ONLINE SUBSCRIPTION
Hangzhou Tigermed Consulting Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSRC) to issue 13.400000 million A-shares in its initial public offering.
1. Class: A shares
2. Stock code: 300347
3. Stock abbreviation: Tigermed Consulting
4. Issuing volume: 13.400000 million shares
5. Par value: CNY1.00 per share
6. Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
7. Targeted listing bourse: Shenzhen Stock Exchange
8. Offline placement volume: 6.700000 million shares
9. Online offering volume: 6.700000 million shares
10. Price: CNY37.88 per share
11. Offline subscription period: 07 August 2012
12. Online subscription date: 07 August 2012.
Date: 2012-07-30
Title: IPO
Hangzhou Tigermed Consulting Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSCR) to issue 13.4000 million A-shares in its initial public offering, which is structured as follows:
1.Class: A shares
2.Size: 13.4000 million shares
3.Par value: CNY1.00 per share
4.Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
5.Targeted listing bourse: Shenzhen Stock Exchange
6.Offline placement volume: 6.7000 million shares
7.Online offering volume:6.7000 million shares
8.IPO price inquiry period: from 31 July 2012 to 02 August 2012
9.IPO price determined: 06 August 2012
10.Offline subscription date:07 August 2012
11.Online subscription date: 07 August 2012
12.Expected listing date:N/A.